<DOC>
	<DOC>NCT02290210</DOC>
	<brief_summary>The purpose of this study is to assess safety, PK/PD and Urate Lowering Effect of URC102 in gout patients with hyperuricemia</brief_summary>
	<brief_title>Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients</brief_title>
	<detailed_description />
	<mesh_term>Gout</mesh_term>
	<mesh_term>Hyperuricemia</mesh_term>
	<criteria>Diagnosed with gout Participated in other clinical study within 12 weeks prior to enrollment, and received an investigational product (including placebo)</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>